


{"id":40208,"date":"2021-12-04T00:18:00","date_gmt":"2021-12-03T22:18:00","guid":{"rendered":"https:\/\/newserver.fyb.de\/allen-overy-advises-vision-healthcare-on-acquisition-of-vitamaze\/"},"modified":"2021-12-04T00:18:00","modified_gmt":"2021-12-03T22:18:00","slug":"allen-overy-advises-vision-healthcare-on-acquisition-of-vitamaze","status":"publish","type":"post","link":"https:\/\/www.fyb.de\/en\/allen-overy-advises-vision-healthcare-on-acquisition-of-vitamaze\/","title":{"rendered":"Allen &amp; Overy advises Vision Healthcare on acquisition of Vitamaze"},"content":{"rendered":"<p>Munich\/ Frank\u00adfurt \u2014 Vision Health\u00adcare, a consu\u00admer health\u00adcare company with an exten\u00adsive port\u00adfo\u00adlio of self-care brands and over-the-coun\u00adter products in seve\u00adral Euro\u00adpean count\u00adries, has acqui\u00adred Vitamaze GmbH (Vitamaze). Vision Health\u00adcare is head\u00adquar\u00adte\u00adred in Belgium.<\/p>\n<p>Vitamaze, based in Heidel\u00adberg, Germany, was foun\u00added in 2015 and is a leading Euro\u00adpean supplier of vitamins, mine\u00adrals and dietary supple\u00adments (VMS). The company opera\u00adtes predo\u00admi\u00adnantly through Amazon and e\u2011pharma channels.<\/p>\n<p>Vision Health\u00adca\u00adre\u2019s exten\u00adsive VMS and digi\u00adtal marke\u00adting exper\u00adtise provi\u00addes Vitamaze with opti\u00admal condi\u00adti\u00adons for further growth, based on the company\u2019s own expe\u00adri\u00adence in sales via Amazon and e\u2011pharma chan\u00adnels. At the same time, Vision Health\u00adcare Group bene\u00adfits from Vitama\u00adze\u2019s exper\u00adtise. The acqui\u00adsi\u00adtion is in line with Vision Health\u00adca\u00adre\u2019s corpo\u00adrate stra\u00adtegy to further expand its leading direct-to-consu\u00admer health\u00adcare tech\u00adno\u00adlogy plat\u00adform for VMS and beauty and perso\u00adnal care products in Europe.<\/p>\n<p>Allen &amp; Overy has exten\u00adsive exper\u00adtise in the life scien\u00adces sector. This enab\u00adled the team to deve\u00adlop a deep under\u00adstan\u00adding of the busi\u00adness chal\u00adlenges as well as the regu\u00adla\u00adtory envi\u00adron\u00adment on the mandate. The Life Scien\u00adces prac\u00adtice at Allen &amp; Overy compri\u00adses around 20 specia\u00adlist lawy\u00aders in Germany and covers the full range of legal issues, inclu\u00adding cross-border clients. Globally, the divi\u00adsion has more than 90 specia\u00adlists with a deep yet tech\u00adni\u00adcal under\u00adstan\u00adding of the entire life scien\u00adces sector.<\/p>\n<p><strong>Advi\u00adsors Vision Health\u00adcare: Allen &amp;&nbsp;Overy<\/strong><br>\nLead <strong>part\u00adner Dr. Alex\u00adan\u00adder Veith<\/strong> and asso\u00adciate Linda Mayer (both Corporate\/ M&amp;A\/ Life Scien\u00adces, Munich) as well as coun\u00adsel Dr. Roman Kasten (Corporate\/Private Equity, Frank\u00adfurt) and Eda Zhuleku (Life Sciences\/Medical Law, Munich). The exten\u00added team also included part\u00adners Dr. Heike Weber (Tax Law, Frank\u00adfurt), Dr. Jens Matthes (IP, D\u00fcssel\u00addorf) as well as coun\u00adsel Dr. Sebas\u00adtian Schulz (Labor Law) and Peter Wehner (Pensi\u00adons). The team also included senior asso\u00adcia\u00adtes Stefa\u00adnie G\u00fcnther (life sciences\/public law, all Frank\u00adfurt), Catha\u00adrina Glugla (data protec\u00adtion), Anna Kr\u00e4ling (IP, both D\u00fcssel\u00addorf) and asso\u00adcia\u00adtes Sven Bisch\u00adoff (tax law) and Barbara Angene (employ\u00adment law, both Frankfurt).<\/p>\n<p>Senior Asso\u00adciate Alvaro Sanchez-Bordona (Madrid) advi\u00adsed on Spanish law.<\/p>\n<p><strong>About Allen &amp;&nbsp;Overy<\/strong><\/p>\n<p>Allen &amp; Overy is an inter\u00adna\u00adtio\u00adnal law firm with appro\u00adxi\u00adm\u00adately 5,500 employees, inclu\u00adding appro\u00adxi\u00adm\u00adately 550 part\u00adners, in more than 40 loca\u00adti\u00adons world\u00adwide. An up-to-date over\u00adview of Allen &amp; Over\u00ady\u2019s offices can be found here: allenovery.com\/locations.<\/p>\n<p>Allen &amp; Overy is repre\u00adsen\u00adted in Germany at its offices in D\u00fcssel\u00addorf, Frank\u00adfurt am Main, Hamburg and Munich with appro\u00adxi\u00adm\u00adately 220 lawy\u00aders, inclu\u00adding 49 part\u00adners. The lawy\u00aders advise leading natio\u00adnal and inter\u00adna\u00adtio\u00adnal compa\u00adnies prima\u00adrily in the areas of banking, finance and capi\u00adtal markets law, corpo\u00adrate law and M&amp;A, tax law as well as other areas of busi\u00adness law. www.allenovery.de<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Munich\/ Frank\u00adfurt \u2014 Vision Health\u00adcare, a consu\u00admer health\u00adcare company with an exten\u00adsive port\u00adfo\u00adlio of self-care brands and over-the-coun\u00ad\u00adter products in seve\u00adral Euro\u00adpean count\u00adries, has acqui\u00adred Vitamaze GmbH (Vitamaze). Vision Health\u00adcare is head\u00adquar\u00adte\u00adred in Belgium. Vitamaze, based in Heidel\u00adberg, Germany, was foun\u00added in 2015 and is a leading Euro\u00adpean supplier of vitamins, mine\u00adrals and dietary supplements&nbsp;[\u2026]<\/p>\n","protected":false},"author":2,"featured_media":39124,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"wp_typography_post_enhancements_disabled":false,"footnotes":""},"categories":[886,1364,1366,1367,1368,1371],"tags":[],"class_list":["post-40208","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-general-en","category-featured-en","category-news-en","category-lawyers-tax-advisors-auditors-en","category-lawyers-tax-consultants-auditors","category-deals-en"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v25.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Allen &amp; Overy advises Vision Healthcare on acquisition of Vitamaze - FYB Financial Yearbook<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.fyb.de\/en\/allen-overy-advises-vision-healthcare-on-acquisition-of-vitamaze\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Allen &amp; Overy advises Vision Healthcare on acquisition of Vitamaze - FYB Financial Yearbook\" \/>\n<meta property=\"og:description\" content=\"Munich\/ Frank\u00adfurt \u2014 Vision Health\u00adcare, a consu\u00admer health\u00adcare company with an exten\u00adsive port\u00adfo\u00adlio of self-care brands and over-the-coun\u00adter products in seve\u00adral Euro\u00adpean count\u00adries, has acqui\u00adred Vitamaze GmbH (Vitamaze). Vision Health\u00adcare is head\u00adquar\u00adte\u00adred in Belgium. Vitamaze, based in Heidel\u00adberg, Germany, was foun\u00added in 2015 and is a leading Euro\u00adpean supplier of vitamins, mine\u00adrals and dietary supple\u00adments [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.fyb.de\/en\/allen-overy-advises-vision-healthcare-on-acquisition-of-vitamaze\/\" \/>\n<meta property=\"og:site_name\" content=\"FYB Financial Yearbook\" \/>\n<meta property=\"article:published_time\" content=\"2021-12-03T22:18:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.fyb.de\/wp-content\/uploads\/2021\/12\/vitamaze_produkt_vitamin-b12-1000_dose_front.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"514\" \/>\n\t<meta property=\"og:image:height\" content=\"725\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Tatjana Anderer\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Tatjana Anderer\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.fyb.de\/en\/allen-overy-advises-vision-healthcare-on-acquisition-of-vitamaze\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.fyb.de\/en\/allen-overy-advises-vision-healthcare-on-acquisition-of-vitamaze\/\"},\"author\":{\"name\":\"Tatjana Anderer\",\"@id\":\"https:\/\/www.fyb.de\/en\/#\/schema\/person\/4308b3086925bc8567ceba3ebd69b4ce\"},\"headline\":\"Allen &amp; Overy advises Vision Healthcare on acquisition of Vitamaze\",\"datePublished\":\"2021-12-03T22:18:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.fyb.de\/en\/allen-overy-advises-vision-healthcare-on-acquisition-of-vitamaze\/\"},\"wordCount\":446,\"publisher\":{\"@id\":\"https:\/\/www.fyb.de\/en\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.fyb.de\/en\/allen-overy-advises-vision-healthcare-on-acquisition-of-vitamaze\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2021\/12\/vitamaze_produkt_vitamin-b12-1000_dose_front.jpeg\",\"articleSection\":[\"General\",\"Featured\",\"News\",\"Lawyers\/Tax-advisors\/Auditors\",\"Lawyers, tax consultants, auditors\",\"DEALS\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.fyb.de\/en\/allen-overy-advises-vision-healthcare-on-acquisition-of-vitamaze\/\",\"url\":\"https:\/\/www.fyb.de\/en\/allen-overy-advises-vision-healthcare-on-acquisition-of-vitamaze\/\",\"name\":\"Allen &amp; Overy advises Vision Healthcare on acquisition of Vitamaze - FYB Financial Yearbook\",\"isPartOf\":{\"@id\":\"https:\/\/www.fyb.de\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.fyb.de\/en\/allen-overy-advises-vision-healthcare-on-acquisition-of-vitamaze\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.fyb.de\/en\/allen-overy-advises-vision-healthcare-on-acquisition-of-vitamaze\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2021\/12\/vitamaze_produkt_vitamin-b12-1000_dose_front.jpeg\",\"datePublished\":\"2021-12-03T22:18:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.fyb.de\/en\/allen-overy-advises-vision-healthcare-on-acquisition-of-vitamaze\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.fyb.de\/en\/allen-overy-advises-vision-healthcare-on-acquisition-of-vitamaze\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.fyb.de\/en\/allen-overy-advises-vision-healthcare-on-acquisition-of-vitamaze\/#primaryimage\",\"url\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2021\/12\/vitamaze_produkt_vitamin-b12-1000_dose_front.jpeg\",\"contentUrl\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2021\/12\/vitamaze_produkt_vitamin-b12-1000_dose_front.jpeg\",\"width\":514,\"height\":725},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.fyb.de\/en\/allen-overy-advises-vision-healthcare-on-acquisition-of-vitamaze\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.fyb.de\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Allen &amp; Overy advises Vision Healthcare on acquisition of Vitamaze\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.fyb.de\/en\/#website\",\"url\":\"https:\/\/www.fyb.de\/en\/\",\"name\":\"FYB Financial Yearbook\",\"description\":\"For Your Business\",\"publisher\":{\"@id\":\"https:\/\/www.fyb.de\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.fyb.de\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.fyb.de\/en\/#organization\",\"name\":\"FYB Financial Yearbook\",\"url\":\"https:\/\/www.fyb.de\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.fyb.de\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/06\/logo.svg\",\"contentUrl\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/06\/logo.svg\",\"caption\":\"FYB Financial Yearbook\"},\"image\":{\"@id\":\"https:\/\/www.fyb.de\/en\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.fyb.de\/en\/#\/schema\/person\/4308b3086925bc8567ceba3ebd69b4ce\",\"name\":\"Tatjana Anderer\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.fyb.de\/en\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/11708a5289b743e6290bae8e4109e97efec1cb1ae5c7065f0bfc5c36f28c7757?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/11708a5289b743e6290bae8e4109e97efec1cb1ae5c7065f0bfc5c36f28c7757?s=96&d=mm&r=g\",\"caption\":\"Tatjana Anderer\"},\"description\":\"Gr\u00fcnderin des FYB-Verlag\",\"sameAs\":[\"http:\/\/neu.fyb.de\"],\"url\":\"https:\/\/www.fyb.de\/en\/author\/tanderer\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Allen &amp; Overy advises Vision Healthcare on acquisition of Vitamaze - FYB Financial Yearbook","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.fyb.de\/en\/allen-overy-advises-vision-healthcare-on-acquisition-of-vitamaze\/","og_locale":"en_US","og_type":"article","og_title":"Allen &amp; Overy advises Vision Healthcare on acquisition of Vitamaze - FYB Financial Yearbook","og_description":"Munich\/ Frank\u00adfurt \u2014 Vision Health\u00adcare, a consu\u00admer health\u00adcare company with an exten\u00adsive port\u00adfo\u00adlio of self-care brands and over-the-coun\u00adter products in seve\u00adral Euro\u00adpean count\u00adries, has acqui\u00adred Vitamaze GmbH (Vitamaze). Vision Health\u00adcare is head\u00adquar\u00adte\u00adred in Belgium. Vitamaze, based in Heidel\u00adberg, Germany, was foun\u00added in 2015 and is a leading Euro\u00adpean supplier of vitamins, mine\u00adrals and dietary supple\u00adments [&hellip;]","og_url":"https:\/\/www.fyb.de\/en\/allen-overy-advises-vision-healthcare-on-acquisition-of-vitamaze\/","og_site_name":"FYB Financial Yearbook","article_published_time":"2021-12-03T22:18:00+00:00","og_image":[{"width":514,"height":725,"url":"https:\/\/www.fyb.de\/wp-content\/uploads\/2021\/12\/vitamaze_produkt_vitamin-b12-1000_dose_front.jpeg","type":"image\/jpeg"}],"author":"Tatjana Anderer","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Tatjana Anderer","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.fyb.de\/en\/allen-overy-advises-vision-healthcare-on-acquisition-of-vitamaze\/#article","isPartOf":{"@id":"https:\/\/www.fyb.de\/en\/allen-overy-advises-vision-healthcare-on-acquisition-of-vitamaze\/"},"author":{"name":"Tatjana Anderer","@id":"https:\/\/www.fyb.de\/en\/#\/schema\/person\/4308b3086925bc8567ceba3ebd69b4ce"},"headline":"Allen &amp; Overy advises Vision Healthcare on acquisition of Vitamaze","datePublished":"2021-12-03T22:18:00+00:00","mainEntityOfPage":{"@id":"https:\/\/www.fyb.de\/en\/allen-overy-advises-vision-healthcare-on-acquisition-of-vitamaze\/"},"wordCount":446,"publisher":{"@id":"https:\/\/www.fyb.de\/en\/#organization"},"image":{"@id":"https:\/\/www.fyb.de\/en\/allen-overy-advises-vision-healthcare-on-acquisition-of-vitamaze\/#primaryimage"},"thumbnailUrl":"https:\/\/www.fyb.de\/wp-content\/uploads\/2021\/12\/vitamaze_produkt_vitamin-b12-1000_dose_front.jpeg","articleSection":["General","Featured","News","Lawyers\/Tax-advisors\/Auditors","Lawyers, tax consultants, auditors","DEALS"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.fyb.de\/en\/allen-overy-advises-vision-healthcare-on-acquisition-of-vitamaze\/","url":"https:\/\/www.fyb.de\/en\/allen-overy-advises-vision-healthcare-on-acquisition-of-vitamaze\/","name":"Allen &amp; Overy advises Vision Healthcare on acquisition of Vitamaze - FYB Financial Yearbook","isPartOf":{"@id":"https:\/\/www.fyb.de\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.fyb.de\/en\/allen-overy-advises-vision-healthcare-on-acquisition-of-vitamaze\/#primaryimage"},"image":{"@id":"https:\/\/www.fyb.de\/en\/allen-overy-advises-vision-healthcare-on-acquisition-of-vitamaze\/#primaryimage"},"thumbnailUrl":"https:\/\/www.fyb.de\/wp-content\/uploads\/2021\/12\/vitamaze_produkt_vitamin-b12-1000_dose_front.jpeg","datePublished":"2021-12-03T22:18:00+00:00","breadcrumb":{"@id":"https:\/\/www.fyb.de\/en\/allen-overy-advises-vision-healthcare-on-acquisition-of-vitamaze\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.fyb.de\/en\/allen-overy-advises-vision-healthcare-on-acquisition-of-vitamaze\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.fyb.de\/en\/allen-overy-advises-vision-healthcare-on-acquisition-of-vitamaze\/#primaryimage","url":"https:\/\/www.fyb.de\/wp-content\/uploads\/2021\/12\/vitamaze_produkt_vitamin-b12-1000_dose_front.jpeg","contentUrl":"https:\/\/www.fyb.de\/wp-content\/uploads\/2021\/12\/vitamaze_produkt_vitamin-b12-1000_dose_front.jpeg","width":514,"height":725},{"@type":"BreadcrumbList","@id":"https:\/\/www.fyb.de\/en\/allen-overy-advises-vision-healthcare-on-acquisition-of-vitamaze\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.fyb.de\/en\/"},{"@type":"ListItem","position":2,"name":"Allen &amp; Overy advises Vision Healthcare on acquisition of Vitamaze"}]},{"@type":"WebSite","@id":"https:\/\/www.fyb.de\/en\/#website","url":"https:\/\/www.fyb.de\/en\/","name":"FYB Financial Yearbook","description":"For Your Business","publisher":{"@id":"https:\/\/www.fyb.de\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.fyb.de\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.fyb.de\/en\/#organization","name":"FYB Financial Yearbook","url":"https:\/\/www.fyb.de\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.fyb.de\/en\/#\/schema\/logo\/image\/","url":"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/06\/logo.svg","contentUrl":"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/06\/logo.svg","caption":"FYB Financial Yearbook"},"image":{"@id":"https:\/\/www.fyb.de\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.fyb.de\/en\/#\/schema\/person\/4308b3086925bc8567ceba3ebd69b4ce","name":"Tatjana Anderer","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.fyb.de\/en\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/11708a5289b743e6290bae8e4109e97efec1cb1ae5c7065f0bfc5c36f28c7757?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/11708a5289b743e6290bae8e4109e97efec1cb1ae5c7065f0bfc5c36f28c7757?s=96&d=mm&r=g","caption":"Tatjana Anderer"},"description":"Gr\u00fcnderin des FYB-Verlag","sameAs":["http:\/\/neu.fyb.de"],"url":"https:\/\/www.fyb.de\/en\/author\/tanderer\/"}]}},"_links":{"self":[{"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/posts\/40208","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/comments?post=40208"}],"version-history":[{"count":0,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/posts\/40208\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/media\/39124"}],"wp:attachment":[{"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/media?parent=40208"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/categories?post=40208"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/tags?post=40208"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}